Unjha Formulations Resultados de beneficios anteriores
Pasado controles de criterios 5/6
Unjha Formulations's earnings have been declining at an average annual rate of -1.4%, while the Personal Products industry saw earnings growing at 8.6% annually. Revenues have been growing at an average rate of 11.9% per year. Unjha Formulations's return on equity is 29.1%, and it has net margins of 4.3%.
Información clave
-1.4%
Tasa de crecimiento de los beneficios
2.3%
Tasa de crecimiento del BPA
| Crecimiento de la industria Personal Products | 7.9% |
| Tasa de crecimiento de los ingresos | 11.9% |
| Rentabilidad financiera | 29.1% |
| Margen neto | 4.3% |
| Próxima actualización de resultados | 08 Nov 2024 |
Actualizaciones de resultados anteriores recientes
Recent updates
Desglose de ingresos y gastos
Cómo gana y gasta dinero Unjha Formulations. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
|---|---|---|---|---|
| 30 Jun 24 | 187 | 8 | 6 | 0 |
| 31 Mar 24 | 185 | 3 | 6 | 0 |
| 31 Dec 23 | 169 | 2 | 6 | 0 |
| 30 Sep 23 | 146 | -2 | 6 | 0 |
| 30 Jun 23 | 144 | 4 | 5 | 0 |
| 31 Mar 23 | 132 | 3 | 5 | 0 |
| 31 Dec 22 | 145 | 4 | 5 | 0 |
| 30 Sep 22 | 153 | 6 | 6 | 0 |
| 30 Jun 22 | 128 | -2 | 6 | 0 |
| 31 Mar 22 | 142 | 3 | 6 | 0 |
| 31 Dec 21 | 131 | 1 | 5 | 0 |
| 30 Sep 21 | 116 | 0 | 5 | 0 |
| 30 Jun 21 | 115 | 3 | 5 | 0 |
| 31 Mar 21 | 100 | 1 | 5 | 0 |
| 31 Dec 20 | 96 | 1 | 5 | 0 |
| 30 Sep 20 | 93 | 2 | 5 | 0 |
| 30 Jun 20 | 101 | 2 | 5 | 0 |
| 31 Mar 20 | 108 | 3 | 4 | 0 |
| 31 Dec 19 | 113 | 5 | 4 | 0 |
| 30 Sep 19 | 111 | 5 | 4 | 0 |
| 30 Jun 19 | 113 | 5 | 4 | 0 |
| 31 Mar 19 | 114 | 3 | 4 | 0 |
| 31 Dec 18 | 109 | 2 | 5 | 0 |
| 30 Sep 18 | 114 | 3 | 5 | 0 |
| 30 Jun 18 | 115 | 4 | 5 | 0 |
| 31 Mar 18 | 113 | 3 | 5 | 0 |
| 31 Dec 17 | 117 | 3 | 7 | 0 |
| 30 Sep 17 | 124 | 2 | 6 | 0 |
| 30 Jun 17 | 123 | 1 | 6 | 0 |
| 31 Mar 17 | 122 | 3 | 6 | 0 |
| 31 Dec 16 | 119 | 3 | 6 | 0 |
| 30 Sep 16 | 113 | 2 | 6 | 0 |
| 30 Jun 16 | 112 | 3 | 5 | 0 |
| 31 Mar 16 | 104 | 3 | 5 | 0 |
| 31 Dec 15 | 100 | 5 | 10 | 0 |
| 30 Sep 15 | 99 | 7 | 10 | 0 |
| 30 Jun 15 | 91 | 5 | 4 | 0 |
| 31 Mar 15 | 90 | 2 | 6 | 0 |
| 31 Dec 14 | 86 | 2 | 22 | 0 |
| 30 Sep 14 | 80 | 2 | 38 | 0 |
| 30 Jun 14 | 75 | 1 | 63 | 0 |
| 31 Mar 14 | 67 | 1 | 10 | 0 |
| 31 Dec 13 | 63 | 2 | 19 | 0 |
Ingresos de calidad: 531762 has high quality earnings.
Margen de beneficios creciente: 531762's current net profit margins (4.3%) are higher than last year (2.9%).
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: 531762's earnings have declined by 1.4% per year over the past 5 years.
Acelerando crecimiento: 531762's earnings growth over the past year (88.9%) exceeds its 5-year average (-1.4% per year).
Beneficios vs. Industria: 531762 earnings growth over the past year (88.9%) exceeded the Personal Products industry 21.9%.
Rentabilidad financiera
Alta ROE: 531762's Return on Equity (29.1%) is considered high.